Latest News
U.S. FDA Accepts New Drug Application for Gilead’s Once-Daily, Single-Tablet Quad HIV Regimen |
![]() |
News
- Read Gilead's 2010 Annual Report
- Gilead Sciences to Release Fourth Quarter and Year End 2011 Financial Results on Thursday, February 2, 2012
- Gilead Initiates Phase 2 Clinical Trial Evaluating GS-7340, A Low-Dose Novel Prodrug of Tenofovir for the Treatment of HIV
- U.S. Food and Drug Administration Approves New Formulations of Viread® for Use by Children Living With HIV
- View all news
Events
- February 2, 2012
Q4 YE 2011 Earnings
Foster City, CA - February 15 - 16, 2012
Leerink Swan Global Healthcare Conference
New York, NY - March 5 - 8, 2012
19th Conference on Retroviruses and Opportunistic Infections
Seattle, WA - View all events



